Organometallics
Article
2C, C(Ar)), 135.4 (s, 2C, C(Ar)), 130.4 (s, 2C, C(Ar)), 129.3−121.6
(om, 32C, CH(Ar)), 67.2 (bs, 2C, CH(Cy)), 66.9 (bs, 2C, CH(Cy)),
49.9 (d, JCP = 34.0, 2C, CH2(Bn)), 48.8 (d, JCP = 15.0, 2C,
CH2(Bn)), 30.7 (s, 2C, CH2(Cy)), 30.1 (s, 2C, CH2(Cy)), 24.5 (s, 2C,
CH2(Cy)), 24.3 (s, 2C, CH2(Cy)).
31P NMR (CDCl3, 121.44 MHz) δ (ppm) 176.6 (s); 1H NMR
(CDCl3, 400 MHz) δ (ppm) (J (Hz)) 7.97−7.00 (om, 24H, CH(Ar)),
2
2
3
4.26 (m, 2H, OCH), 2.96 (d, JHP = 12.0, 6H, CH3(NMe)), 2.90 (d,
3
3JHP = 12,0, 6H, CH3(NMe)), 1.25 (d, JHH = 4.0, 6H, CH3); 13C
NMR (CDCl3, 100 MHz) δ (ppm) (J (Hz)) 145.6 (s, 2C, C(Ar)),
2
Synthesis of Bis(diamidophosphite) Ligand (R,R;Sal,Sal;R,R)-
2a. (R,R)-N,N′-Dimethylcyclohexane-1,2-diamine (0.51 g, 3.6 mmol)
and NEt3 (1.50 mL, 10.8 mmol) were dissolved in 10 mL of toluene.
PCl3 (0.4 mL, 4.6 mmol) dissolved in 5 mL of toluene was added
dropwise at 0 °C. The mixture was warmed to room temperature and
was stirred for 2 h. The formation of the chlorodiazaphospholidine was
monitored by phosphorus NMR spectroscopy (δ 174.5 ppm), being
complete after this period. The solvent and the excess PCl3 were
thoroughly removed under reduced pressure to afford a viscous oil.
This oil was dissolved in toluene (10 mL), and DMAP (2.6 × 10−3 g,
0.021 mmol) was added. A solution of a stoichiometric amount of the
diol (S,S)-2,3-butanediol (0.16 g, 1.8 mmol) and 1.3 mL of NEt3 (9,0
mmol) in toluene (10 mL) was added dropwise in three portions at 0
°C. After the mixture was stirred overnight at room temperature,
hexane (5 mL) was added and the white precipitate of triethylamine
hydrochloride was filtered off. The solvent was removed under
vacuum, and a brownish oil was obtained and used without further
purification: yield 0.41 g (53.7%); HR-MS/ESI (m/z) C20H40N4O2P2
431.2697 [MH]+; [α]298(c 1.0, CH2Cl2) = −125.48°; 31P NMR
145.0 (s, 2C, C(Ar)), 142.2 (d, JCP = 6.0, 2C, C(Ar)), 133.1 (s, 2C,
C(Ar)), 132.7 (s, 2C, C(Ar)), 131.7 (s, 2C, C(Ar)), 131.3 (s, 2C,
C(Ar)), 130.7 (s, 2C, C(Ar)), 129.7−121.4 (om, 24C, CH(Ar)), 72,6
2
3
2
(dd, JCP = 19.0, JCP = 6.0, 2C, OCH), 37.7 (d, JCP = 45.0, 2C,
2
3
CH3(NMe)), 35.5 (d, JCP = 25.4, 2C, CH3(NMe)), 16.8 (d, JCP
3.5, 2C, CH3).
=
(R;Ral,Ral;R)-3c: yield 0.40 g (59%); HR-MS/ESI (m/z)
C51H48N4O4P2 843.3210 [MH]+; [α]298(c 1.0, CH2Cl2) = −325.13°;
31P NMR (CDCl3, 101.25 MHz) δ (ppm) 168.9 (s); 1H NMR
(CDCl3, 400 MHz) δ (ppm) (J (Hz)) 7.99−7.00 (om, 24H, CH(Ar)),
3.86 (m, 2H, OCH), 3.78 (m, 2H, OCH2), 3.68 (m, 2H, OCH2), 3.05
3
3
(d, JHP = 12.0, 6H, CH3(NMe)), 2.85 (d, JHP = 10.0, 6H,
CH3(NMe)), 1.42 (s, 6H, CH3); 13C NMR (CDCl3, 100 MHz) δ
(ppm) (J (Hz)) 144.9 (d, 2JCP = 5.0, 2C, C(Ar)), 142.7 (d, 2JCP = 7.0,
2C, C(Ar)), 133.0−121.1 (om, 36C, 12C(Ar) + 24CH(Ar)), 109.7 (s,
2
1C, O2CMe2), 77.9 (s, 2C, OCH), 64.3 (d, JCP = 7.0, 2C, OCH2),
38.0 (d, JCP = 44.2, 2C, CH3(NMe)), 35.1 (d, JCP = 26.2, 2C,
CH3(NMe)), 27.2 (s, 2C, CH3).
2
2
(S;Sal;S)-3d: yield 0.39 g (51.0%); HR-MS/ESI (m/z)
C64H48N4O2P2 967.3317 [MH]+; [α]298(c 1.0, CH2Cl2) = +202.93°;
31P NMR (CDCl3, 121.44 MHz) δ (ppm) 173.6 (s); 1H NMR
(CDCl3, 400 MHz) δ (ppm) (J (Hz)) 8.07−6.86 (om, 34H, CH(Ar)),
1
(CDCl3, 121.44 MHz) δ (ppm) 139.1 (s); H NMR (CDCl3, 400
MHz) δ (ppm) (J (Hz)) 4.06 (m, 2H, OCH), 2.69 (d, 3JHP = 16.0, 6H,
3
CH3(NMe)), 2.66 (m, 2H, CH(Cy)), 2.56 (d, JHP = 16.0, 6H,
CH3(NMe)), 2.30 (m, 2H, CH(Cy)), 2.10−1.00 (om, 16H,
4
3
5.98 (d, JHP = 2.0, 2H, CH(Ar)), 2.20 (d, JHP = 16.0, 6H,
3
CH2(Cy)), 1.11 (d, JHH = 4.0, 6H, CH3); 13C NMR (CDCl3, 100
CH3(NMe)), 1.98 (d, JHP = 8,0, 6H, CH3(NMe)); 13C NMR
(CDCl3, 100 MHz) δ (ppm) (J (Hz)) 151.3 (d, JCP = 8.0, 2C,
C(Ar)), 144.7 (d, JCP = 5.0, 2C, C(Ar)), 141.8 (d, JCP = 6.0, 2C,
C(Ar)), 134.2−120.1 (54C, 18C(Ar) + 36CH(Ar)), 36.5 (d, JCP
43.0, 2C, CH3(NMe)), 34.0 (d, JCP = 25.0, 2C, CH3(NMe)).
3
2
3
MHz, 298 K) δ (ppm) (J (Hz)) 71.8 (dd, JCP = 10.0, JCP = 3.0, 2C,
2
2
2
OCH), 69.4 (d, JCP = 7.0, 2C, CH(Cy)), 65.8 (d, JCP = 9.0, 2C,
CH(Cy)), 32.7 (d, 2JCP = 37.0, 2C, CH3(NMe)), 30.2 (d, 2JCP = 11.0,
2C, CH3(NMe)), 29.4 (s, 2C, CH2(Cy)), 29.1 (s, 2C, CH2(Cy)), 24.3
2
2
=
2
3
(s, 2C, CH2(Cy)), 24.2 (s, 2C, CH2(Cy)), 16.2 (d, JCP = 1.0, 2C,
(R,Sal,R)-3d: yield 0.34 g (44%); HR-MS/ESI (m/z) C64H48N4O2P2
CH3)
967.3322 [MH]+; [α]298(c 1.0, CH2Cl2) = −28.09°; 31P NMR
General Procedure for the Synthesis of Bis-
(diamidophosphites) (R;Sal,Sal;R)-3a, (S;Sal,Sal;S)-3a, (R;Ral,Ral;R)-
3c, (S;Sal;S)-3d, and (R;Sal;R)-3d. (R)- and (S)-N,N′-dimethyl-1,1′-
binaphthyldiamine (0.5 g, 1.6 mmol) and ethyldiisopropylamine (2.20
mL, 12.6 mmol) were dissolved in 10 mL of toluene at 0 °C. PCl3
(0.30 mL, 3.5 mmol) dissolved in 5 mL of toluene was added dropwise
at 0 °C. The mixture was warmed to room temperature and was stirred
for 20 h. The formation of the chlorodiazaphosphepine was monitored
by phosphorus NMR spectroscopy (δ 205.0 ppm), being complete
after this period. The solvent and excess PCl3 and ethyldiisopropyl-
amine were thoroughly removed under reduced pressure to afford a
viscous oil. This oil was dissolved in toluene (10 mL), and DMAP (2.6
× 10−3 g, 0.021 mmol) was added. The corresponding diol (0.8 mmol;
((S,S)-2,3-butanediol) in toluene (10 mL) or (−)-2,3-O-isopropyli-
dene-D-threitol or (R)-/(S)-1,1′-bi-2-naphthol) in THF (10 mL)) and
triethylamine (2.2 mL, 15.8 mmol) were added in three portions at 0
°C. After it was stirred overnight at room temperature, the mixture was
cooled at 4 °C. The white precipitate of amine hydrochloride was
filtered off. The solvent was removed under vacuum, and a yelow solid
was obtained and used without further purification.
1
(CDCl3, 101.25 MHz) δ (ppm) 174.6 (s); H NMR (CDCl3, 400
MHz) δ (ppm) (J (Hz)) 8.08−6.96 (om, 36H, CH(Ar)), 2.68 (d, 3JHP
= 13.6, 6H, CH3(NMe)), 2.21 (d,3JHP = 9.2, 6H, CH3(NMe)); 13C
NMR (CDCl3, 100 MHz) δ (ppm) (J (Hz)) 150.6 (d, 2JCP = 8.0, 2C,
2
2
C(Ar)), 144.8 (d, JCP = 5.0, 2C, C(Ar)), 141.7 (d, JCP = 6.0, 2C,
2
C(Ar)), 134.7−121.7 (54C, 18C(Ar) + 36CH(Ar)), 38.0 (d, JCP
50.0, 2C, CH3(NMe)), 34.7 (d, JCP = 24.0, 2C, CH3(NMe)).
=
2
(S,Ral,S)-3d: yield 0.39 g (51%); HR-MS/ESI (m/z) C64H48N4O2P2
967.3322 [MH]+; [α]298(c 1.0, CH2Cl2) = +23.30°.
General Procedure for the Synthesis of Selenide Deriva-
tives. 0.15 mmol of ligand dissolved in 2 mL of toluene in the
presence of 2.4 mmol of selenium powder was stirred under N2 for 24
h at room temperature. The reaction mixture was filtered through
Celite. The compounds were characterized by 31P NMR (101 MHz)
in toluene.
General Procedure for the Synthesis of Rhodium Com-
plexes. A solution of the corresponding bis(diamidophosphite) ligand
(0.1 mmol) in toluene (5 mL) was added dropwise to a vigorously
stirred CH2Cl2 solution (20 mL) of [Rh(COD)2]BF4 (0.041 g, 0.10
mmol), in the presence of free COD when not freshly prepared (0.032
g, 0.3 mmol). The mixture was stirred for an additional 15 min and
concentrated to dryness at reduced pressure. The solid was washed
with ether (3 × 8 mL) and dried under vacuum.
(R;Sal,Sal;R)-3a: yield 0.29 g (48%); HR-MS/ESI (m/z)
C48H44N4O2P2 771.3021 [MH]+; [α]298(c 1.0, CH2Cl2) = −263.35°;
31P NMR (CDCl3, 101.25 MHz) δ (ppm) 178.3 (s); 1H NMR
(CDCl3, 400 MHz) δ (ppm) (J (Hz)) 8.06−7.02 (om, 24H, CH(Ar)),
[Rh(COD)((R,R;Sal,Sal;R,R)-1a)]BF4: yellow solid; yield 0.062 g
3
(60%); mp 222−226 °C dec; 31P NMR (CDCl3, 121.44 MHz) δ
4.40 (m, 2H, OCH), 3.03 (d, JHP = 12.0, 6H, CH3(NMe)), 2.99 (d,
3
3JHP = 12.0, 6H, CH3(NMe)), 1.21 (d, JHH = 8,0, 6H, CH3); 13C
1
1
(ppm) (J (Hz)) 139.8 (d, JPRh = 228.3 Hz); H NMR (CD2Cl2, 500
MHz) δ (ppm) (J (Hz)) 7.84−6.96 (m, 20H, CH(Ar)), 5.70 (pt, 2JHH
NMR (CDCl3, 100 MHz) δ (ppm) (J (Hz)) 144.9 (d, 2JCP = 5.0, 2C,
2
= 3JHP = 12.5, 2H, CH2(Bn)), 5.42 (bs, 2H, CH(COD)), 5.29 (bs, 2H,
C(Ar)), 141.9 (d, JCP = 6.0, 2C, C(Ar)), 133.1 (s, 2C, C(Ar)), 132.8
2
(s, 2C, C(Ar)), 131.8 (s, 2C, C(Ar)), 131.2 (s, 2C, C(Ar)), 130.8 (s,
CH(COD)), 4.56 (bs, 4H, 2OCH + 2CH2(Bn)), 4.19 (dd, JHH
=
3
2
2C, C(Ar)), 129.0−121.3 (om, 26C, 2C(Ar) + 24CH(Ar)), 73.7 (dd,
17.5, JHP = 7.5, 2H, CH2(Bn)), 3.63 (d, JHH = 15.0, 2H, CH2(Bn)),
2.91 (m, 2H, CH(Cy)), 2.65 (m, 2H, CH(Cy)), 2.44 (m, 4H, CH2
(COD)), 2.28 (m, 4H, CH2(COD)), 2.15−0.75 (om, 16H,
3
2
2JCP = 23.5, JCP = 2.5, 2C, OCH), 37.8 (d, JCP = 45.0, 2C,
2
3
CH3(NMe)), 35.4 (d, JCP = 26.0, 2C, CH3(NMe)), 14.8 (d, JCP
5.0, 2C, CH3).
=
3
CH2(Cy)), 1.11 (d, JHH = 5.0, 6H, CH3); HR-MS (ESI) m/z
(S;Sal,Sal;S)-3a: yield 0.32 g (51%); HR-MS/ESI (m/z)
945.3874 [M]+. Anal. Calcd for C52H68BF4N4O2P2Rh: C, 60.47; H,
6.64; N, 5.42. Found: C, 59.55; H, 6.65; N, 5.82.
C48H44N4O2P2 771.3004 [MH]+; [α]298(c 1.0, CH2Cl2) = +327.15°;
I
dx.doi.org/10.1021/om400119q | Organometallics XXXX, XXX, XXX−XXX